Michael Lehrke

13PUBLICATIONS
55CO-AUTHORS
MortalityRespiratory diseasesHaematologyCardiology (incl. cardiovascular diseases)Medical biochemistry - lipids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 10, 2025
Proenkephalin A 119-159 (penKid) and mortality in stable patients at high cardiovascular risk.

Matthias Rau, Berkan Kurt, Oliver Hartmann

|Nov 29, 2024
Repeat cardiovascular-related procedures and real-world treatment in high-risk patients with hypercholesterolemia or mixed dyslipidemia.

Michael Lehrke, Sabrina Müller, Ulf Maywald

|Jun 22, 2024
Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT.

Ildiko Lingvay, John Deanfield, Steven E Kahn

|Jan 29, 2024
Evolocumab-Based LDL-C Management in High and Very High Cardiovascular Risk Patients in German Clinical Practice: The HEYMANS Study.

Michael Lehrke, Anja Vogt, Volker Schettler

|Nov 24, 2023
Mapping cardiac remodeling in chronic kidney disease.

Nadine Kaesler, Mingbo Cheng, James Nagai

|Apr 18, 2023
Empagliflozin Improves Left Atrial Strain in Patients With Type 2 Diabetes: Data From a Randomized, Placebo-Controlled Study.

Kirsten Thiele, Matthias Rau, Julian Grebe

Pageof 3

Frequent Collaborators

4 joint publications

Nikolaus Marx

3 joint publications

Mathias Hohl

3 joint publications

Michael Böhm

2 joint publications

Uwe Fraass